Article info

PDF

Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink

Authors

  • John-Michael Gamble School of Pharmacy, Faculty of Science, University of Waterloo, Waterloo, Ontario, Canada School of Pharmacy, Memorial University of Newfoundland, St. John’s, Newfoundland and Labrador, Canada PubMed articlesGoogle scholar articles
  • Eugene Chibrikov School of Pharmacy, Faculty of Science, University of Waterloo, Waterloo, Ontario, Canada School of Pharmacy, Memorial University of Newfoundland, St. John’s, Newfoundland and Labrador, Canada Faculty of Medicine, Memorial University of Newfoundland, St. John’s, Newfoundland and Labrador, Canada PubMed articlesGoogle scholar articles
  • William K Midodzi Faculty of Medicine, Memorial University of Newfoundland, St. John’s, Newfoundland and Labrador, Canada PubMed articlesGoogle scholar articles
  • Laurie K Twells School of Pharmacy, Memorial University of Newfoundland, St. John’s, Newfoundland and Labrador, Canada Faculty of Medicine, Memorial University of Newfoundland, St. John’s, Newfoundland and Labrador, Canada PubMed articlesGoogle scholar articles
  • Sumit R Majumdar Division of General Internal Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr John-Michael Gamble; jm.gamble{at}uwaterloo.ca
View Full Text

Citation

Gamble J, Chibrikov E, Midodzi WK, et al
Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink

Publication history

  • Received June 22, 2018
  • Revised August 27, 2018
  • Accepted August 31, 2018
  • First published October 8, 2018.
Online issue publication 
October 08, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.